Drugs / Influenza Virus Vaccine, Monovalent A/H5N1 A/Vietnam/1203/04
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03472976 | Jun 2018 → Mar 2019 | avian influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza Virus Vaccine, Monovalent A/H5N1 A/Vietnam/1203/04 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03472976 ↗ |
| Known as | MIV A/H5N1 | “Based on recent reports, we hypothesized that preapplication of topical imiquimod followed by intradermal (ID) vaccination with monovalent inactivated influenza A/H5N1 vaccine...” PMID 33852718 ↗ Nov 2021 |
| Modality | Vaccine | “Inactivated monovalent subvirion H5N1 vaccine containing hemagglutinin (HA) of A/Vietnam/1203/04” NCT03472976 ↗ |